Lucid Diligence Brief: WellBeam $10M Series A
Lucid Diligence Brief: WellBeam $10M Series A Professional audiences only. Not…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…
Lucid Diligence Brief: Philips and Cortechs.ai quantitative neuroimaging partnership
Lucid Diligence Brief: Philips and Cortechs.ai quantitative neuroimaging…
Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T deal
Lucid Diligence Brief: Tempest Therapeutics and Factor Bioscience dual-CAR T…
Lucid Diligence Brief: Avanzanite Bioscience €32m Series A
Lucid Diligence Brief: Avanzanite Bioscience €32m Series A Professional…
AI in Healthcare and Digital Health Video Recap—November 18, 2025
Here’s your biweekly AI in Healthcare and Digital Health video brief on…
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics…
AI in Healthcare and Digital Health Today—November 17, 2025
This week's AI in Healthcare and Digital Health update highlights…
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal
Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal…
Lucid Diligence Brief: Merck to acquire Cidara Therapeutics
Lucid Diligence Brief: Merck to acquire Cidara Therapeutics Professional…
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast…